ABO-Incompatible Donor

  • Takashi Kenmochi
  • Takehide Asano
  • Naotake Akutsu
  • Taihei Ito


Human ABO blood type, which was discovered in 1901 by Tagareli and Landsteiner [1], is a major immunological barrier in organ transplantation because of a development of severe rejection due to the humoral reaction between A or B antigens and anti-A or anti-B antibodies. ABO-incompatible kidney transplantation was first performed in 1952 by Hume et al. for the patient of renal failure [2]. The transplanted kidney, however, did not function at all. Starzl et al. also performed ABO-incompatible kidney transplantation in four patients in 1964 and succeeded long-term graft survival in one patient [3, 4]. However, since a success rate was extremely low, ABO-incompatible kidney transplantation generally ceased to be performed [5]. Thereafter, in 1981, Slapak et al. reported the efficacy of plasmapheresis for the rejection after kidney transplantation with ABO incompatibility [6]. Alexandre et al. first performed ABO-incompatible kidney transplantation using the designed protocol using plasma exchange for pretransplant removal of anti-A and anti-B antibodies and splenectomy for long-term graft survival [7–9].

In Japan, Takahashi et al. have introduced the first ABO-incompatible kidney transplantation in 1989 using double-filtered plasmapheresis (DFPP) with immunoabsorption for the removal of antibodies and splenectomy which resulted in long-term graft survival [10–14]. This clinical success encouraged us to promote ABO-incompatible living kidney transplantation in Japan, and 2,218 patients underwent ABO-incompatible living kidney transplantation from January 1 to December 31 [15]. The number of ABO-incompatible living kidney transplantation has increased year and year, and currently, about 25 % of living kidney transplantation is ABO-incompatible transplantation in Japan.

In addition to kidney transplantation, ABO-incompatible transplantation has been introduced into liver transplantation [16] and pancreas transplantation [17] in Japan.

ABO-incompatible donor is considered as an immunologically marginal donor for the recipient. Pretreatment for the recipient, which includes pretransplant immunosuppression and improved desensitization protocol as well as careful monitoring of the antibody titer both before and after transplantation, achieved the improved graft survival that is almost equal to that in ABO-compatible kidney transplantation. Especially in Japan, ABO-incompatible kidney transplantation has become widely adopted due to a severe shortage of deceased donors.

In this chapter, we describe the current status of ABO-incompatible kidney transplantation in Japan and our experiences of simultaneous pancreas and kidney transplantation from ABO-incompatible live donors in a single institution.


Kidney Transplantation Pancreatic Juice Deceased Donor Pancreas Transplant Acute Cellular Rejection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Tagareli A, Landsteiner K. A hundred years later. Transplantation. 2001;72:3–7.CrossRefGoogle Scholar
  2. 2.
    Hume DH, Merril JP, Hiller BF, Thorn GW. Experiences with renal homo-transplantation in the human: report of nine cases. J Clin Invest. 1995;34:327–82.CrossRefGoogle Scholar
  3. 3.
    Starzl TE, Marchioro TL, Rifkind D, Holmes JH, Rowlands Jr DT, Waddell WR. Renal homografts in patients with major donor recipient blood group incompatibilities. Surgery. 1964;55:195–200.PubMedCentralPubMedGoogle Scholar
  4. 4.
    Starzl TE, Tzakis A, Makowka L, Banner B, Demetrius A, Ramsey G, Duquesnoy R, Griffin M. The definition of ABO factors in transplantation: relation of other humoral antibody states. Transplant Proc. 1987;19:4492–7.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Gleason RE, Murray JE. Report from kidney transplant registry: analysis of variables in the function of human kidney transplants. Transplantation. 1967;52:343–59.CrossRefGoogle Scholar
  6. 6.
    Slapak M, Naik RB, Lee HA. Renal transplant in a patient with major donor-recipient blood group incompatibility. Reversal of acute rejection by the use of modified plasmapheresis. Transplantation. 1981;31:4–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Alexandre GP, De Bruyere M, Squifflet JP, Moriau M, Latinne D, Pirson Y. Human ABO incompatible living donor renal homografts. Neth J Med. 1985;28:231–4.PubMedGoogle Scholar
  8. 8.
    Alexandre GP, Squifflet JP, De Bruyère M, Latinne D, Reding R, Gianello P, Carlier M, Pirson Y. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc. 1987;19(6):4538–42.PubMedGoogle Scholar
  9. 9.
    Alexandre GPJ, Latinne D, Gianello P. Performed cytotoxic antibodies and ABO-incompatible grafts. Clin Transplant. 1991;5:583–93.Google Scholar
  10. 10.
    Takahashi K, Agishi T, Oba S, et al. Extracorporeal plasma treatment for extending indication of kidney transplantation: ABO-incompatible and preformed antibody-positive kidney transplantation, Therapeutic plasmapheresis, vol. IX. Cleveland: ESAO; 1990. p. 61–3.Google Scholar
  11. 11.
    Takahashi K, Tanabe K, Ooba S, Yagisawa T, Nakazawa H, Teraoka S, Hayasaka Y, Kawaguchi H, Ito K, Toma H. Prophylactic use of a new immunosuppressive agent deoxyspergualin in patients with kidney transplantation from ABO-incompatible or preformed antibody positive donors. Transplant Proc. 1991;26:1078–82.Google Scholar
  12. 12.
    Takahashi K, Sonda K, Okuda H, Nakazawa H, Kawaguchi H, Toma H, Agishi T, Ota K, Nakabayashi M, Takeda Y. The first report of a successful delivery in a woman with an ABO-incompatible kidney transplantation. Transplantation. 1993;56:1288–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Takahashi K, Yagisawa T, Sonda K, Kawaguchi H, Yamaguchi Y, Toma H, Agishi T, Ota K. A ABO-incompatible kidney transplantation in a single-center trial. Transplant Proc. 1993;25:271–3.PubMedGoogle Scholar
  14. 14.
    Tanabe K, Takahashi K, Sonda K, Tokumoto T, Ishikawa N, Kawai T, Fuchinoue S, Oshima T, Yagisawa T, Nakazawa H, Goya N, Koga S, Kawaguchi H, Ito K, Toma H, Agishi T, Ota K. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation. 1998;65:224–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Saito K, Takahashi K. Registry 2012 of ABO-incompatible living kidney transplantation in Japan. In: Takahashi K, Tanaka K, editors. The new strategies of ABO incompatible transplantation-2013-(Japanese). Niigata: Japanese Society for ABO-incompatible transplantation; 2013. p. 3–18.Google Scholar
  16. 16.
    Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology. 2008;47(1):143–52.PubMedCrossRefGoogle Scholar
  17. 17.
    Kenmochi T, Asano T, Maruyama M, Saigo K, Akutsu N, Iwashita C, Ohtsuki K, Suzuki A, Miyazaki M. Living donor pancreas transplantation in Japan. J Hepatobiliary Pancreat Sci. 2010;17(2):101–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Takahashi K. ABO-incompatible kidney transplantation. Amsterdam: Elsevier; 2011.Google Scholar
  19. 19.
    Takahashi K, Saito K, Tanabe K, et al. Multicenter cooperative study group. First report of 7-year survey on ABO-incompatible kidney transplantation in Japan. Clin Exp Nephrol. 2001;5:119–25.CrossRefGoogle Scholar
  20. 20.
    Sutherland DER. Pancreas and islet transplantation. II. Clinical trials. Diabetologia. 1981;20:435–50.PubMedCrossRefGoogle Scholar
  21. 21.
    Sutherland DER, Goetz FC, Najarian JS. Living-related donor segmental pancreatectomy for transplantation. Transplant Proc. 1980;12:19–25.PubMedGoogle Scholar
  22. 22.
    Gruessner RWG, Sutherland DER. Simultaneous kidney and segmental pancreas transplants from living related donors: the first two successful cases. Transplantation. 1996;61:1265–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Gruessner RWG, Kendall DM, Drangstveit MB, Gruessner AC, Sutherland DER. Simultaneous pancreas-kidney transplantation from living donors. Ann Surg. 1997;226:471–82.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Otsuki K, Kenmochi T, Saigo K, Maruyama M, Akutsu N, Iwashita C, Kono T, Okazumi S, Asano T, Yoshikawa K. Evaluation of segmental pancreatic function using 11C-methionine positron emission tomography for safe operation of living donor pancreas transplantation. Transplant Proc. 2008;40:2562–4.PubMedCrossRefGoogle Scholar
  25. 25.
    Otsuki K, Yoshikawa K, Kenmochi T, Saigo K, Maruyama M, Akutsu N, Iwashita C, Ito T, Kono T, Okazumi S, Asano T. Evaluation of segmental pancreatic function using 11C-methionine positron emission tomography for safe living donor operation of pancreas transplantation. Transplant Proc. 2011;43(9):3273–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Maruyama M, Kenmochi T, Akutsu N, Saigo K, Iwashita C, Otsuki K, Ito T, Asano T. Laparoscopic-assisted distal pancreatectomy and nephrectomy from a live donor. J Hepatobiliary Pancreat Sci. 2010;17:193–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  • Takashi Kenmochi
    • 1
  • Takehide Asano
    • 2
  • Naotake Akutsu
    • 2
  • Taihei Ito
    • 1
  1. 1.Department of Organ Transplant SurgeryFujita Health UniversityToyoake CityJapan
  2. 2.Department of Surgery and Clinical Research CenterChiba-East National HospitalChiba CityJapan

Personalised recommendations